The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033.

The Viral Gastroenteritis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Viral Gastroenteritis Market:
https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

According to The Business Research Company’s Viral Gastroenteritis Global Market Report 2024, The viral gastroenteritis market size has grown strongly in recent years. It will grow from $6.34 billion in 2023 to $6.7 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to prevalence of viral infections, global hygiene practices, advancements in diagnostics, global travel and tourism, climate and environmental factors.The viral gastroenteritis market size is expected to see steady growth in the next few years. It will grow to $8.1 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%.

The rising awareness about hygiene and sanitation is expected to drive the growth of the viral gastroenteritis market in the future. Hygiene practices, such as handwashing and proper waste disposal, along with sanitation measures, including water treatment and clean living environments, play a crucial role in preventing the spread of viruses that cause gastroenteritis. By interrupting the fecal-oral route of transmission and reducing contamination, these practices contribute to community health by lowering the risk and impact of gastroenteritis outbreaks. For example, a survey by Citron Hygiene found that before the pandemic, only 11% of people washed their hands for the recommended 18–20 seconds, but during the pandemic, this number increased to 25%. Additionally, 67% of individuals reported heightened awareness of hygiene and fear of germs due to the COVID-19 epidemic. Consequently, the growing awareness of hygiene and sanitation practices is propelling the growth of the viral gastroenteritis market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

The viral gastroenteritis market covered in this report is segmented –
1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Top Major Players
Pfizer Inc.,
Abbvie Inc.,
Bayer AG,
Sanofi S.A.,
AstraZeneca Plc.

The viral gastroenteritis market report table of contents includes:
1. Executive Summary
2. Viral Gastroenteritis Market Characteristics
3. Viral Gastroenteritis Market Trends And Strategies
4. Viral Gastroenteritis Market - Macro Economic Scenario
5. Global Viral Gastroenteritis Market Size and Growth
6. Viral Gastroenteritis Market Segmentation
7. Viral Gastroenteritis Market Regional And Country Analysis
..............
34. Key Mergers And Acquisitions In The Viral Gastroenteritis Market
35. Viral Gastroenteritis Market Future Outlook and Potential Analysis
36. Appendix

List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
..............
Table 76: Pfizer Inc. Financial Performance
Table 77: AbbVie Inc. Financial Performance
Table 78: Bayer AG Financial Performance
Table 79: Sanofi S.A. Financial Performance
Table 80: AstraZeneca Plc. Financial Performance

Read Related Reports :
https://topprnews.com/otc-drug-and-dietary-supplement-market-trends/
https://goodprnews.com/otc-drug-and-dietary-supplement-market-growth/

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model